Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.

Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...

Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the U.S. Food and Drug ...

Morgantown’s Civilian Police Review and Advisory Board has set a review of the Morgantown Police Department’s officer-worn ...

Minister for Social Security and Disabilities, Sir Stephen Timms also reassured existing PIP claimants with an outstanding ...

Neuren Pharmaceuticals was among the best-performing ASX 200 stocks in morning trade after securing a rare pediatric disease ...

As Stellantis chairman John Elkann interviews CEO candidates, deciding how many of the automaker's 14 brands have a viable ...

Saturday’s hostage-taking and fatal shooting of a police officer at UPMC Memorial Hospital in York sent shockwaves throughout ...

RBI raises loan limits for urban cooperative banks, adjusts real estate exposure norms, and extends deadline for prudential ...

Senate bills 12 and 1565 would withhold funding from Texas public schools that don’t comply with the state’s DEI ban.

Pakistan Banks Association (PBA) Chairman Zafar Masood said on Monday that the Federal Board of Revenue (FBR) should not push ...